Immunoproliferative Disorders
Also known as: Immunoproliferative Disorder / Malignant immunoproliferative disease, unspecified / Immunoproliferative disease (morphologic abnormality) / Immunoproliferative disorder (disorder) / Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified / Lymphoproliferative disorder / Lymphoproliferative Disorders / Lymphoproliferative disorder (morphologic abnormality) / Lymphoproliferative disorder NOS / Lymphoproliferative disorder (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06769 | Bendamustine | 1 | Recruiting | 2 |
| DB15722 | CYNK-001 | 1 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 2 |
| DB17280 | OriCar-017 | 1 | Not Yet Recruiting | 1 |
| DB04974 | Rimiducid | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
| DB04974 | Rimiducid | 1 / 2 | Recruiting | 1 |
| DB05299 | Keyhole limpet hemocyanin | 2 | Completed | 1 |
| DB16582 | Lisocabtagene maraleucel | 2 | Completed | 1 |
| DB06334 | Tucidinostat | 2 | Unknown Status | 1 |
| DB09053 | Ibrutinib | 3 | Withdrawn | 1 |
| DB18403 | Zilovertamab | 3 | Withdrawn | 1 |
| DB00531 | Cyclophosphamide | Not Available | No Longer Available | 1 |
| DB01073 | Fludarabine | Not Available | No Longer Available | 1 |
| DB04974 | Rimiducid | Not Available | No Longer Available | 1 |